📰 Optune Gio News
Page 3 - Optune Gio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Optune Gio. Real-time updates on events, politics, business and more.
February 22, 2024
Full year 2023 net revenues of $509 million and fourth quarter net revenues of $134 million PMA application for TTFields in NSCLC accepted for review by U.S. Food and Drug...
February 22, 2024
NVCR earnings call for the period ending December 31, 2023.
February 22, 2024
NVCR earnings call for the period ending December 31, 2023.
January 8, 2024
Preliminary full year 2023 net revenues of $509 million and fourth quarter net revenues of $134 million PMA application for TTFields in NSCLC submitted for review to U.S. Food and Drug...
January 1, 2024
Since being diagnosed in 2018, the Vikings' assistant coach has fought with determination and established a renewed outlook on life, providing a source of inspiration to so many along the way
January 1, 2024
NovoCure Limited (NASDAQ:NVCR – Get Free Report) has been given a consensus rating of “Moderate Buy” by the nine ratings firms that are presently covering the company, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12 […]
December 19, 2023
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.
November 17, 2023
(BPT) - Some people just know how to live. One great example is Mike Hugo, who learns from stumbles and turns them into victory — tackling anything he wants to do with vigor and perseverance. …
November 10, 2023
Novocure today announced that research on Tumor Treating Fields therapy, including new data from the phase 2 2-THE-TOP trial and real-world evidence from patients diagnosed with glioblastoma and...